NCT04094272View on ClinicalTrials.gov

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

May 1, 2019

Study Completion Date

June 1, 2019

Conditions
Pulmonary Artery HypertensionChronic Hepatitis c
Interventions
DIAGNOSTIC_TEST

transthoracic doppler-echocardiography (TTE)

Transthoracic doppler-echocardiography (TTE) in patients with a new diagnosis of HCV before and after treatment with DAA medication.

Trial Locations (1)

4600

Kantonsspital Olten, Olten

All Listed Sponsors
lead

Kantonsspital Olten

OTHER

NCT04094272 - Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection | Biotech Hunter | Biotech Hunter